Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This Phase 2 study has been designed to determine the safety and efficacy of repeated
treatment sessions of VDMN-21 patch at two dose strengths as compared to a matched vehicle
control patch in subjects with verruca vulgaris